Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder : protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trial

Source
Brain, behavior, & immunity - health - ISSN 2666-3546-41 (2024) p. 1-7
Author(s)

Immune-based machine learning prediction of diagnosis and illness state in schizophrenia and bipolar disorder

Source
Brain, behavior, and immunity - ISSN 0889-1591-122 (2024) p. 422-432
Author(s)

Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder

Source
Brain, behavior, & immunity - health - ISSN 2666-3546-38 (2024) p. 1-7
Author(s)
    Katlyn Nemani, Livia De Picker, Faith Dickerson, Marion Leboyer, Michele Santacatterina, Fumika Ando, Gillian Capichioni, Thomas E. Smith, Jamie Kammer, Kawtar El Abdellati, Manuel Morrens, Violette Coppens, Emily Katsafanas, Andrea Origoni, Sabahat Khan, Kelly Rowe, R. Sarah Ziemann, Ryad Tamouza, Robert H. Yolken, Donald C. Goff

Continuous theta burst stimulation for bipolar depression : a multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites

Source
Journal of affective disorders - ISSN 0165-0327-361 (2024) p. 693-701
Author(s)

Unveiling transitions in disease states : study of depressive and anxiety symptom networks over time

Source
Depression and anxiety - ISSN 1091-4269-2024 (2024) p. 1-18
Author(s)